Penserra Capital Management LLC Tekla Life Sciences Investors Put Options Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HQL
# of Institutions
75Shares Held
9.51MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$48.5 Million1.1% of portfolio
-
Morgan Stanley New York, NY490KShares$6.92 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.62 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.89 Million0.14% of portfolio
-
Absolute Investment Advisers LLC400KShares$5.65 Million0.67% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...